Genetic Engineering
Genetically altered mice predict toxicity for individual targeted cancer therapy
Published in Gene Therapy Weekly, April 22nd, 2004
"Current trends foretell the use of cancer treatments customized to each patient. Genetic and molecular profiling of tumors and an increasing number of molecule-targeted therapies contribute to making this a reality," wrote scientists at the University of North Carolina.
"However, as targets of anticancer therapies become specific proteins or pathways, unanticipated side effects may emerge. In addition, the chronic use of these treatments may contribute to the development of degenerative toxicity not predicted by short-term...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2004-04-22)
More Articles from Gene Therapy Weekly
- Gastroenterology
Inducible nitric oxide synthase sensitizes colorectal cancer to radiation - Gynecology
The ceruloplasmin promoter shows an affinity for ovarian tumors - Biological Therapy
Silenced clusterin-apolipoprotein J gene causes cancer cells to implode - Gene Transfer
A new cleavage product gives real-time information about transgene activity - Immunology
Gene therapy in a murine multiple sclerosis model corrects disease - Pediatric Cancer
Herpes simplex virus thymidine kinase genes diminish nearby neuroblastoma cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
